ConcertAI Integrates TeraRecon to Enhance Healthcare AI

ConcertAI has announced the integration of TeraRecon, a leading medical imaging analysis company, into its operations. This merger is set to create the industry’s first unified AI software-as-a-service (SaaS) company, combining electronic medical records, genomic data, and medical image data into a single, integrated network. The aim is to enhance clinical research and decision support applications, marking a substantial shift in AI innovation within the healthcare sector.

This integration means ConcertAI, known for its enterprise AI and real-world data (RWD) solutions, is advancing artificial intelligence, machine learning, and deep learning innovations from life sciences to full deployment within healthcare provider workflows.

“Serving 1,300 clinical sites globally, TeraRecon is a Best in KLAS solution provider for radiology, oncology, cardiology, neurology, and vascular surgery,” said Jeff Elton, PhD, CEO of ConcertAI. He emphasized that TeraRecon’s solutions are independent of any one manufacturer’s imaging equipment or PACS system, allowing a unified clinical workflow to enhance efficiencies and deliver actionable insights to physicians.

The integration aims to develop advanced AI-augmented diagnostic and interpretive capabilities, bridging biomedical innovation and care coordination. Much of this progress will be achieved through software-as-a-medical devices, utilizing retrospective images and electronic medical record (EMR) data for model development and validation.